Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

Pearl Quijada, Haruhiro Toko, Kimberlee M. Fischer, Brandi Bailey, Patrick Reilly, Kristin D. Hunt, Natalie A. Gude, Daniele Avitabile, Mark A. Sussman

Research output: Contribution to journalArticle

Abstract

Bone marrow-derived cells to treat myocardial injury improve cardiac function and support beneficial cardiac remodeling. However, survival of stem cells is limited due to low proliferation of transferred cells. To demonstrate long-term potential of c-kit(+) bone marrow stem cells (BMCs) enhanced with Pim-1 kinase to promote positive cardiac remodeling. Lentiviral modification of c-kit(+) BMCs to express Pim-1 (BMCeP) increases proliferation and expression of prosurvival proteins relative to BMCs expressing green fluorescent protein (BMCe). Intramyocardial delivery of BMCeP at time of infarction supports improvements in anterior wall dimensions and prevents left ventricle dilation compared with hearts treated with vehicle alone. Reduction of the akinetic left ventricular wall was observed in BMCeP-treated hearts at 4 and 12 weeks after infarction. Early recovery of cardiac function in BMCeP-injected hearts facilitated modest improvements in hemodynamic function up to 12 weeks after infarction between cell-treated groups. Persistence of BMCeP is improved relative to BMCe within the infarct together with increased recruitment of endogenous c-kit(+) cells. Delivery of BMC populations promotes cellular hypertrophy in the border and infarcted regions coupled with an upregulation of hypertrophic genes. Thus, BMCeP treatment yields improved structural remodeling of infarcted myocardium compared with control BMCs. Genetic modification of BMCs with Pim-1 may serve as a therapeutic approach to promote recovery of myocardial structure. Future approaches may take advantage of salutary BMC actions in conjunction with other stem cell types to increase efficacy of cellular therapy and improve myocardial performance in the injured myocardium.

Original languageEnglish
Pages (from-to)77-86
Number of pages10
JournalCirculation Research
Volume111
Issue number1
DOIs
Publication statusPublished - Jun 22 2012

Fingerprint

Bone Marrow Cells
Stem Cells
Infarction
Proto-Oncogene Proteins c-pim-1
Myocardium
Recovery of Function
Green Fluorescent Proteins
Hypertrophy
Heart Ventricles
Dilatation
Up-Regulation
Hemodynamics
Cell Proliferation
Wounds and Injuries
Therapeutics
Population
Genes

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Quijada, P., Toko, H., Fischer, K. M., Bailey, B., Reilly, P., Hunt, K. D., ... Sussman, M. A. (2012). Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. Circulation Research, 111(1), 77-86. https://doi.org/10.1161/CIRCRESAHA.112.265207

Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. / Quijada, Pearl; Toko, Haruhiro; Fischer, Kimberlee M.; Bailey, Brandi; Reilly, Patrick; Hunt, Kristin D.; Gude, Natalie A.; Avitabile, Daniele; Sussman, Mark A.

In: Circulation Research, Vol. 111, No. 1, 22.06.2012, p. 77-86.

Research output: Contribution to journalArticle

Quijada, P, Toko, H, Fischer, KM, Bailey, B, Reilly, P, Hunt, KD, Gude, NA, Avitabile, D & Sussman, MA 2012, 'Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.', Circulation Research, vol. 111, no. 1, pp. 77-86. https://doi.org/10.1161/CIRCRESAHA.112.265207
Quijada, Pearl ; Toko, Haruhiro ; Fischer, Kimberlee M. ; Bailey, Brandi ; Reilly, Patrick ; Hunt, Kristin D. ; Gude, Natalie A. ; Avitabile, Daniele ; Sussman, Mark A. / Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. In: Circulation Research. 2012 ; Vol. 111, No. 1. pp. 77-86.
@article{d527f0289eff4f83933dd4d90d88c0d2,
title = "Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.",
abstract = "Bone marrow-derived cells to treat myocardial injury improve cardiac function and support beneficial cardiac remodeling. However, survival of stem cells is limited due to low proliferation of transferred cells. To demonstrate long-term potential of c-kit(+) bone marrow stem cells (BMCs) enhanced with Pim-1 kinase to promote positive cardiac remodeling. Lentiviral modification of c-kit(+) BMCs to express Pim-1 (BMCeP) increases proliferation and expression of prosurvival proteins relative to BMCs expressing green fluorescent protein (BMCe). Intramyocardial delivery of BMCeP at time of infarction supports improvements in anterior wall dimensions and prevents left ventricle dilation compared with hearts treated with vehicle alone. Reduction of the akinetic left ventricular wall was observed in BMCeP-treated hearts at 4 and 12 weeks after infarction. Early recovery of cardiac function in BMCeP-injected hearts facilitated modest improvements in hemodynamic function up to 12 weeks after infarction between cell-treated groups. Persistence of BMCeP is improved relative to BMCe within the infarct together with increased recruitment of endogenous c-kit(+) cells. Delivery of BMC populations promotes cellular hypertrophy in the border and infarcted regions coupled with an upregulation of hypertrophic genes. Thus, BMCeP treatment yields improved structural remodeling of infarcted myocardium compared with control BMCs. Genetic modification of BMCs with Pim-1 may serve as a therapeutic approach to promote recovery of myocardial structure. Future approaches may take advantage of salutary BMC actions in conjunction with other stem cell types to increase efficacy of cellular therapy and improve myocardial performance in the injured myocardium.",
author = "Pearl Quijada and Haruhiro Toko and Fischer, {Kimberlee M.} and Brandi Bailey and Patrick Reilly and Hunt, {Kristin D.} and Gude, {Natalie A.} and Daniele Avitabile and Sussman, {Mark A.}",
year = "2012",
month = "6",
day = "22",
doi = "10.1161/CIRCRESAHA.112.265207",
language = "English",
volume = "111",
pages = "77--86",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

AU - Quijada, Pearl

AU - Toko, Haruhiro

AU - Fischer, Kimberlee M.

AU - Bailey, Brandi

AU - Reilly, Patrick

AU - Hunt, Kristin D.

AU - Gude, Natalie A.

AU - Avitabile, Daniele

AU - Sussman, Mark A.

PY - 2012/6/22

Y1 - 2012/6/22

N2 - Bone marrow-derived cells to treat myocardial injury improve cardiac function and support beneficial cardiac remodeling. However, survival of stem cells is limited due to low proliferation of transferred cells. To demonstrate long-term potential of c-kit(+) bone marrow stem cells (BMCs) enhanced with Pim-1 kinase to promote positive cardiac remodeling. Lentiviral modification of c-kit(+) BMCs to express Pim-1 (BMCeP) increases proliferation and expression of prosurvival proteins relative to BMCs expressing green fluorescent protein (BMCe). Intramyocardial delivery of BMCeP at time of infarction supports improvements in anterior wall dimensions and prevents left ventricle dilation compared with hearts treated with vehicle alone. Reduction of the akinetic left ventricular wall was observed in BMCeP-treated hearts at 4 and 12 weeks after infarction. Early recovery of cardiac function in BMCeP-injected hearts facilitated modest improvements in hemodynamic function up to 12 weeks after infarction between cell-treated groups. Persistence of BMCeP is improved relative to BMCe within the infarct together with increased recruitment of endogenous c-kit(+) cells. Delivery of BMC populations promotes cellular hypertrophy in the border and infarcted regions coupled with an upregulation of hypertrophic genes. Thus, BMCeP treatment yields improved structural remodeling of infarcted myocardium compared with control BMCs. Genetic modification of BMCs with Pim-1 may serve as a therapeutic approach to promote recovery of myocardial structure. Future approaches may take advantage of salutary BMC actions in conjunction with other stem cell types to increase efficacy of cellular therapy and improve myocardial performance in the injured myocardium.

AB - Bone marrow-derived cells to treat myocardial injury improve cardiac function and support beneficial cardiac remodeling. However, survival of stem cells is limited due to low proliferation of transferred cells. To demonstrate long-term potential of c-kit(+) bone marrow stem cells (BMCs) enhanced with Pim-1 kinase to promote positive cardiac remodeling. Lentiviral modification of c-kit(+) BMCs to express Pim-1 (BMCeP) increases proliferation and expression of prosurvival proteins relative to BMCs expressing green fluorescent protein (BMCe). Intramyocardial delivery of BMCeP at time of infarction supports improvements in anterior wall dimensions and prevents left ventricle dilation compared with hearts treated with vehicle alone. Reduction of the akinetic left ventricular wall was observed in BMCeP-treated hearts at 4 and 12 weeks after infarction. Early recovery of cardiac function in BMCeP-injected hearts facilitated modest improvements in hemodynamic function up to 12 weeks after infarction between cell-treated groups. Persistence of BMCeP is improved relative to BMCe within the infarct together with increased recruitment of endogenous c-kit(+) cells. Delivery of BMC populations promotes cellular hypertrophy in the border and infarcted regions coupled with an upregulation of hypertrophic genes. Thus, BMCeP treatment yields improved structural remodeling of infarcted myocardium compared with control BMCs. Genetic modification of BMCs with Pim-1 may serve as a therapeutic approach to promote recovery of myocardial structure. Future approaches may take advantage of salutary BMC actions in conjunction with other stem cell types to increase efficacy of cellular therapy and improve myocardial performance in the injured myocardium.

UR - http://www.scopus.com/inward/record.url?scp=84865401614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865401614&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.112.265207

DO - 10.1161/CIRCRESAHA.112.265207

M3 - Article

VL - 111

SP - 77

EP - 86

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -